5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.84▲ | 5.84▲ | 5.86▼ | 5.89▼ | 5.73▲ |
MA10 | 5.84▲ | 5.87▼ | 5.88▼ | 5.84▲ | 5.70▲ |
MA20 | 5.84▲ | 5.88▼ | 5.87▼ | 5.73▲ | 5.88▼ |
MA50 | 5.87▼ | 5.87▼ | 5.85▼ | 5.72▲ | 6.23▼ |
MA100 | 5.87▼ | 5.84▲ | 5.77▲ | 5.89▼ | 6.46▼ |
MA200 | 5.86▼ | 5.74▲ | 5.63▲ | 6.16▼ | 7.55▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | -0.007▼ | -0.007▼ | 0.025▲ | 0.021▲ |
RSI | 49.302▼ | 43.567▼ | 46.505▼ | 57.801▲ | 46.167▼ |
STOCH | 41.667 | 9.804▼ | 26.795 | 88.053▲ | 66.716 |
WILL %R | -16.667▲ | -75.000▼ | -75.000▼ | -26.667 | -31.618 |
CCI | 85.417 | -96.940 | -129.306▼ | 66.176 | 22.656 |
Monday, May 19, 2025 01:01 PM
TPI Composites, Inc. (NASDAQ: TPIC), today announced its sponsorship of the wind tunnel competition at the World KidWind Challenge, to be held at the American Clean Power Association’s (ACP) ...
|
Monday, May 19, 2025 05:00 AM
In the preceding three months, 8 analysts have released ratings for ACADIA Pharmaceuticals (NASDAQ:ACAD), presenting ... in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP ...
|
Saturday, May 17, 2025 07:00 AM
Acadia Pharmaceuticals strengthens Nuplazid's IP, anticipates stabilization in commercial performance, and eyes future pipeline value. Read more on how ACAD stock is a Buy.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
21/05/25 | 5.90 | 5.93 | 5.82 | 5.85 | 1,253,600 |
20/05/25 | 5.87 | 5.92 | 5.8535 | 5.92 | 691,102 |
19/05/25 | 5.87 | 5.89 | 5.82 | 5.89 | 582,300 |
16/05/25 | 5.91 | 5.91 | 5.85 | 5.88 | 427,242 |
15/05/25 | 5.85 | 5.91 | 5.83 | 5.91 | 520,100 |
14/05/25 | 5.86 | 5.8792 | 5.8002 | 5.84 | 599,666 |
13/05/25 | 5.84 | 5.85 | 5.81 | 5.85 | 860,210 |
12/05/25 | 5.77 | 5.81 | 5.73 | 5.80 | 873,935 |
09/05/25 | 5.73 | 5.75 | 5.72 | 5.73 | 477,722 |
08/05/25 | 5.73 | 5.73 | 5.665 | 5.71 | 371,262 |
|
|
||||
|
|
||||
|
|